Glycyrrhizin (GL) is a triterpenoid saponin found in the root of licorice (Glycyrrhizia glabra L.). It is known that GL has various biological activities, such as an anti-inflammatory effect, 1) an anti-viral effect, 2) interferon-g-inducing activity, 3) and the ability to induce extrathymic T cells. 4) Recently, we reported that (i) three phospholipases A 2 (PLA 2 s) [PA2Y (Tf PL-X, 121 amino acid residues), PA21 (Tf PLA, 122 amino acid residues) and PA2B (lysine-49-PLA 2 , 122 amino acid residues)] are selectively purified from Habu snake venom as GL-binding proteins (gbPs); and (ii) PA2B is a GL-sensitive enzyme in vitro. 5) Therefore, it is of interest to examine the inhibitory effects of GL, glycyrrhetinic acid (GA) and a GA derivative (oGA) on the activity of secretory type IIA PLA 2 (sPLA 2 -IIA) purified from the synovial fluids of patients with rheumatoid arthritis, 6, 7) because (i) sPLA 2 -IIA is a critical modulator of cytokine-mediated synovial inflammation in rheumatoid arthritis 8, 9) ; and (ii) the amino acid sequence of sPLA 2 -IIA has a high homology with that of a GL-sensitive PA2B (Habu snake venom). 5) An attempt was made to selectively purify sPLA 2 -IIA from the rheumatoid synovial fluids as a gbP by means of GL-affinity column chromatography (HPLC), similar to the purification of gbPLA 2 s from Habu snake venom. 5) We also reported that (i) casein kinase II (CK-II) mediates a significant stimulation of the activities of GL-binding enzymes, such as lipoxygenase 3 10) and recombinant HIV-1 proteins [reverse transcriptase 11) and protease 12) ], in vitro; and (ii) the CK-II-mediated phosphorylation of these gbPs is selectively inhibited by oGA and polyphenol-containing antioxidant compounds [quercetin, epigallo-catechin gallate (EGCG) and 8-chloro-3Ј,4Ј,5,7-tetrahydroxy-isoflavone] in vitro. 13, 14) The aim here, therefore, was to characterize GL and oGA as potent inhibitors of the CK-II-mediated stimulation of sPLA 2 -IIA activity in vitro.
In this communication, we describe (i) the selective purification of sPLA 2 -IIA in the heparin-affinity fraction prepared from the synovial fluids of patients with rheumatoid arthritis by means of GL-affinity column chromatography; (ii) the inhibitory effects of GL, GA and oGA on the activity of purified gbPLA 2 (sPLA 2 -IIA) in vitro; and (iii) phosphorylation of gbPLA 2 by CK-II and characterization of GL and oGA as potent inhibitors of the CK-II-mediated stimulation of sPLA 2 -IIA activity in vitro. were kindly supplied by Minophagen Pharmaceutical Co., Ltd. (Tokyo). A 10 mM preparation of these three compounds in 10% dimethylsulfoxide was diluted with sterilized water.
MATERIALS AND METHODS

Chemicals
GL-Affinity Column A GL-affinity column was prepared as originally described by Nakamura et al., 15) ported.
10-14)
Assay of PLA 2 Activity The activity of gbPLA 2 (sPLA 2 -IIA) purified from the synovial fluids of patients with rheumatoid arthritis was measured using NBD-PE as a substrate. Reaction mixtures (total 100 ml) comprising 20 mM Tris-HCl (pH 8.0), 123 mM NBD-PE, 2 mM Ca 2ϩ and the indicated amounts of purified sPLA 2 -IIA were incubated for 10 min at 37°C in the presence or absence of the indicated doses of either GL, GA or oGA. Enzyme reaction was arrested by the addition of 100 ml acetonitrile containing 0.02% acetic acid. NBD-dodecanoic acid produced from NBD-PE by the enzyme reaction in the mixtures was quantitatively measured using a Super ODS column (f 4.6ϫ100 mm, Tosoh Mfg. Co., Ltd., Tokyo). 32 P]ATP (1000 cpm/pmol), purified sPLA 2 -IIA (approx. 1.5 mg), poly-Arg (a CK-II activator, 0.1 mg) and rhCK-II (approx. 50 ng) were incubated for the indicated periods at 30°C, as previously reported. 5, [11] [12] [13] [14] After incubation, the 32 P-labeled sPLA 2 -IIA (approx. 14 kDa) in the reaction mixtures was detected by sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE) followed by autoradiography, as previously reported. [11] [12] [13] [14] 
RESULTS
Selective Purification of sPLA 2 -IIA from the Synovial Fluids of Patients with Rheumatoid Arthritis as a gbP
To partially purify sPLA 2 -IIA from the synovial fluids of patients with rheumatoid arthritis, heparin-binding proteins including sPLA 2 -IIA in the crude fluid (about 15 mg protein) were selectively separated by heparin-affinity column chromatography (HPLC). Elution was carried out with a linear gradient between 0.2 and 1.5 M NaCl (Fig. 1A) . sPLA 2 -IIA was detected in the fractions between 24 and 26 by Western blotting using anti-sPLA 2 -IIA serum (Fig. 1B) . To further purify sPLA 2 -IIA in the heparin-affinity fraction, the fraction (approx. 2.0 mg) was applied onto a GL-affinity column, previously equilibrated with 20 mM HEPES (pH 7.6) containing 0.3 M NaCl and protease inhibitors. Elution was carried out with a linear gradient between 0.3 and 2.0 M NaCl in 20 mM HEPES buffer ( Fig. 2A) . SDS-PAGE revealed sPLA 2 -IIA in the GL-affinity fraction to be a 14 kDa single polypeptide (Fig. 2B) , and sPLA 2 -IIA was detected in the fractions between 18 and 26 by Western blotting using anti-sPLA 2 -IIA serum (Fig. 2C) . These results show that sPLA 2 -IIA in the synovial fluids of patients with rheumatoid arthritis could be selectively purified by GL-affinity column chromatography as a gbP. Since a 20 kDa GL-binding polypeptide (gp20) was detected in the fractions 14-20 (Fig. 2B) , the concentrated fractions 21-23 (undetectable gp20) were used for the present study as a purified sPLA 2 -IIA fraction. [A] The heparin-affinity fraction (approx. 2.0 mg protein) was applied on a GL-affinity HPLC column, equilibrated previously with 20 mM HEPES buffer (pH 7.6) containingInhibitory Effects of GL, GA and oGA on the Activity of Purified sPLA 2 -IIA The inhibitory effects of GL, GA and oGA on the activity of purified sPLA 2 -IIA were examined at pH 8.0 in vitro. Figure 3 shows that (i) oGA inhibits the activity of sPLA 2 -IIA in a dose-dependent manner with a 50% inhibition dose (ID 50 ) of about 10 mM; (ii) GA also inhibits it (ID 50 ϭapprox. 30 mM); and (iii) GL at 100 mM reduces only 27% of sPLA 2 -IIA activity in vitro. Similar inhibitory effects of these three compounds on the activity of purified sPLA 2 -IIA were observed when PC was used as a substrate instead of NBD-PE. However, the inhibitory effects of GL and GA on sPLA 2 -IIA activity were reduced when assayed at pH 8.5, since sPLA 2 -IIA had a lower binding affinity with a GL-affinity column at pH 8.5 (data not shown). These results show that (i) the activity of sPLA 2 -IIA purified from the synovial fluids of patients with rheumatoid arthritis is more sensitive to GA than GL; and (ii) oGA effectively inhibits it in vitro.
Inhibitory Effects of GL and oGA on the CK-II-Mediated Stimulation of sPLA 2 -IIA Activity in Vitro As our previous report demonstrated that three gbPLA 2 s (PA2Y, PA21 and PA2B) purified from Habu snake venom are phosphorylated by CK-II in vitro, 5) a similar experiment was carried out using purified sPLA 2 -IIA by incubation for the indicated periods at 30°C with CK-II and 20 mM [g-32 P]ATP (1000 cpm/pmol) in the presence of poly-Arg (a CK-II activator) in vitro. Phosphorylation of sPLA 2 -IIA by CK-II reached a plateau within 120 min at 30°C (Fig. 4A) . This phosphorylation was markedly inhibited by 50 mM GL (Fig.  4B, lane 4) or 5 mM oGA (lane 5).
The physiological significance of the CK-II-mediated phosphorylation of purified sPLA 2 -IIA on its enzymatic activity was examined in vitro. The PLA 2 activity was stimulated approx. 3.8-fold when purified sPLA 2 -IIA was incubated for 120 min at 30°C with CK-II and cold 20 mM ATP (Fig. 5, column 2) . However, no stimulation of PLA 2 activity was observed when purified sPLA 2 -IIA was incubated with CK-II and 20 mM ATP in the presence of 50 mM GL (Fig. 5,  column 3 ) or 5 mM oGA (column 4). In column 4, the PLA 2 activity was recovered about 85%, as compared with control (column 1). These results suggest that (i) phosphorylation of sPLA 2 -IIA by CK-II induces a significant stimulation of its activity in vitro; and (ii) this stimulation is inhibited by oGA at one-tenth the concentration of GL in vitro.
DISCUSSION
In this study, we found that (i) sPLA 2 -IIA in the heparinaffinity fraction prepared from the synovial fluids of patients with rheumatoid arthritis could be selectively purified by GLaffinity column chromatography (Fig. 2) ; (ii) purified sPLA 2 -IIA functions as a phosphate acceptor for CK-II in vitro (Fig.  4) ; (iii) this phosphorylation induces a significant stimulation 1006 Vol. 24, No. 9 (Fig. 5) ; and (iv) the CK-II-mediated stimulation of sPLA 2 -IIA activity is remarkedly inhibited by oGA (a GA derivative) at one-tenth the concentration of GL (Fig. 5) . These results presented here are similar to our previous reports demonstrating the CK-II-mediated stimulation of the activity of a GL-sensitive PA2B purified from Habu snake venom and the inhibitory effect of oGA on phosphorylation of PA2B by CK-II in vitro.
5) Therefore, it is concluded that (i) phosphorylation of these two gbPLA 2 s (human sPLA 2 -IIA and Habu snake venom PA2B) by CK-II induces a significant stimulation of their enzymatic activitities in vitro; and (ii) this CK-II-mediated stimulation is effectively inhibited by oGA in vitro.
The GA moiety in the GL molecule may be responsible for the inhibition of sPLA 2 -IIA activity, because (i) the activity of sPLA 2 -IIA purified from the synovial fluids of patients with rheumatoid arthritis is more sensitive to GA than GL (Fig. 3) ; and (ii) oGA (ID 50 ϭapprox. 10 mM) at about onetwentieth the concentration of GL effectively inhibits the activity of sPLA 2 -IIA in vitro (Fig. 3) . In contrast, the CK-IImediated phosphorylation of sPLA 2 -IIA was markedly inhibited by 0.5 mM GA or 50 mM GL (Fig. 4) in a manner similar to their inhibitory effects on phosphorylation of PA2B (Habu snake venom) 5) and other GL-binding enzymes (lipoxygenase 3 10) and HIV-1 reverse transcriptase 11) ) by CK-II in vitro. The CK-II-mediated phosphorylation of these two gbPLA 2 s (sPLA 2 -IIA and PA2B) is more sensitive to GL, as compared with the inhibitory effect of GL on their enzymatic activities in vitro. Therefore, it seems likely that the GL-induced inhibition of the CK-II-mediated phosphorylation of these two gbPLA 2 s in vitro may be due to prevent their physiological interaction with CK-II (a GL-binding protein kinase). 17, 18) The oGA-induced inhibition of the CK-II-mediated stimulation of sPLA 2 -IIA activity in vitro is different from the mechanical action of an anti-inflammatory substance, SB-203347 (2-[2-[3,5-bis(trifluoromethyl)sulfonamido]-4-trifluoromethyl-phenoxy] benzonic acid), which directly inhibits the activity of sPLA 2 -IIA (ID 50 ϭapprox. 0.5 mM) from the synovial fluid of patients with rheumatoid arthritis, but exhibits a 40-fold weaker inhibition of 85 kDa PLA 2 (cPLA 2 a-IVA) in vitro. 19) The physiological correlation between the GL-induced inhibition of the CK-II-mediated stimulation of sPLA 2 -IIA activity in vitro and the GL-induced anti-inflammatory effect in vivo remains unclear at present. This correlation will be elucidated by the in vivo experiments for direct detection of the specific phosphorylation of cellular sPLA 2 -IIA with membrane-associated CK-II 17) in interleukin-1 (IL-1)/tumor necrosis factor (TNF)-stimulated cells. This possibility is strongly supported by the following recent reports: (i) sPLA 2 -IIA is the most widely distributed isozyme in humans and rats, 20) and is extremely induced by proinflammatory stimuli, such as bacterial endotoxin, IL-1 and TNF 21) ; (ii) this isozyme is localized in the punctate and perinuclear domains in IL-1/TNF-stimulated cells and is accumulated in the caveolae of cytokine-stimulated cells; 22, 23) and (iii) caveolae are highly enriched in caveolins (structural proteins), b 2 -adrenergic receptor, cAMP-dependent protein kinase (A-kinase) 24) and receptor tyrosine kinases, such as platelet-derived growth factor receptor 25) and ErbB receptor, 26) corresponding signal transduction for metabolic and mitogenic effects, and functions as a lipid scaffold for organizing the molecular interactions of multiple signaling pathways. 27) For understanding clearly the biochemical mechanism involved in the GL-induced anti-inflammatory effect in vivo, further analytical studies will be required (i) to confirm a GL-sensitive sPLA 2 among at least five isozymes (sPLA 2 -IIA, sPLA 2 -IIC, sPLA 2 -IID, sPLA 2 -IIE and sPLA 2 -IIF) 28, 29) of the sPLA 2 -II family in various clinical materials, such as synovial fluid of patients with rheumatoid arthritis and sera of patients with autoimmune diseases; (ii) to characterize the regulatory mechanism of the GL-sensitive sPLA 2 by membrane-associated CK-II or other protein kinases [A-kinase, Ca 2ϩ /phospholipid-dependent protein kinase (C-kinase), mitogen-activated protein kinase (MAP-kinase) and receptor tyrosine kinases] in vivo and in vitro; and (iii) to determine the suppressive effects of GL, GA and oGA on the induction of a GL-sensitive sPLA 2 in the cytokine-mediated response at the cellular level.
